AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . May 20th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Pathogenesis - Cytotoxic T-lymphocyte-associated antigen contributes to CD4 cell loss
AIDS and HIV Wasting Syndrome - Reduced levels of key adipocyte protein may be trigger
AIDS and HIV Therapy - Protease inhibitors affect statin pharmacokinetics
Cytomegalovirus Retinitis - New oral medication halts blindness in AIDS patients
Kaposi Sarcoma - UNC scientist finds chief AIDS cancer needs trauma and virus to get started
Screening - Routine hospital HIV testing identifies patients with undiagnosed infection
AIDS Therapy - 24-week results from phase III study of fusion inhibitor T-20 announced
AIDS Therapy - World Health Organization includes antiretrovirals on essential medicines list
AIDS and HIV Therapy - Cannabinoids have little impact on protease inhibitor levels
AIDS and HIV Therapy - Phase I SBIR grant awarded to advance development of AIDS treatment
AIDS-related Cancer - Rituximab potentiates cisplatin effects by Bcl-2 suppression
Cell Biology - Manganese blocks HIV replication; lab finding points to potential new class of HIV treatments
Epidemiology - South African gold mining giant finds up to 30% of work force is HIV positive
Finance - Biotech company's stock soars on AIDS drug test results
Funding - U.S. pledges to help Caribbean beat back spread of HIV/AIDS
Hepatitis B - 92-week data from study of adefovir dipivoxil in lamivudine-resistant patients presented
Hepatitis C - Roche's Pegasys achieves multiple firsts in landmark hepatitis C trial
Pharmacy Practice - UB launches nation's first program to certify practicing pharmacists as HIV specialists
Policy - U.S. is sending $300 million immediately to newly created Global Fund to Fight AIDS
Professional Training - Medical college scientists launch AIDS prevention research core to help Eastern European colleagues
T-Cell Receptor Peptide - AstraZeneca and T Cell Sciences withdraw opposition to patent
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
